Zhejiang Jolly Pharmaceutical Co.,Ltd.’s Net Profit Rose 41.7% in First Half of 2023

Zhejiang Jolly Pharmaceutical Co.,Ltd. (浙江佐力药业股份有限公司) (300181.SZ) reported a net profit of 201.8 million yuan in the first half of 2023, up 41.7% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, up 13% year-on-year.

At the end of the reporting period, it had 3.5 billion yuan in total assets and 898.9 million yuan in total liabilities, with a liability-to-asset ratio of 25.3%.